Genetic advances in the study of speech and language disorders

Neuron

Volumn 68, Issue 2, 2010, Pages 309-320

  Newbury, D F ^a   Monaco, A P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACTIN ASSOCIATED PROTEIN LIKE 2; MEMBRANE PROTEIN; PROTEIN ATP2C2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG; CNTNAP2 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, HUMAN; FOXP2 PROTEIN, HUMAN; NERVE PROTEIN; REPRESSOR PROTEIN;

CHROMOSOME ABERRATION; DYSPRAXIA; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; LANGUAGE DISABILITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPEECH DISORDER; SPEECH SOUND DISORDER; STUTTERING; GENETIC SCREENING; GENETICS; PROCEDURES;

FORKHEAD TRANSCRIPTION FACTORS; GENETIC TESTING; GENETIC VARIATION; HUMANS; LANGUAGE DISORDERS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; REPRESSOR PROTEINS; SPEECH DISORDERS;

EID: 77957904400     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.10.001     Document Type: Review

References (125)

1. Abecasis G.R., Cardon L.R., Cookson W.O. A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 2000, 66:279-292.
2. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc. Natl. Acad. Sci. USA 2007, 104:17849-17854.
3. Alarcón M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 2008, 82:150-159.
4. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 2008, 82:160-164.
5. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 2008, 82:165-173.
6. Barry J.G., Yasin I., Bishop D.V. Heritable risk factors associated with language impairments. Genes Brain Behav. 2007, 6:66-76.
7. Bartlett C.W., Flax J.F., Logue M.W., Vieland V.J., Bassett A.S., Tallal P., Brzustowicz L.M. A major susceptibility locus for specific language impairment is located on 13q21. Am. J. Hum. Genet. 2002, 71:45-55.
8. Bartlett C.W., Flax J.F., Logue M.W., Smith B.J., Vieland V.J., Tallal P., Brzustowicz L.M. Examination of potential overlap in autism and language loci on chromosomes 2, 7, and 13 in two independent samples ascertained for specific language impairment. Hum. Hered. 2004, 57:10-20.
9. Belloso J.M., Bache I., Guitart M., Caballin M.R., Halgren C., Kirchhoff M., Ropers H.H., Tommerup N., Tümer Z. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur. J. Hum. Genet. 2007, 15:711-713.
10. Bishop D.V. Is specific language impairment a valid diagnostic category? Genetic and psycholinguistic evidence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1994, 346:105-111.
11. Bishop D.V. The role of genes in the etiology of specific language impairment. J. Commun. Disord. 2002, 35:311-328.
12. Blood G.W., Ridenour V.J., Qualls C.D., Hammer C.S. Co-occurring disorders in children who stutter. J. Commun. Disord. 2003, 36:427-448.
13. Bruce H.A., Margolis R.L. FOXP2: Novel exons, splice variants, and CAG repeat length stability. Hum. Genet. 2002, 111:136-144.
14. Carl G.F., Keen C.L., Gallagher B.B., Clegg M.S., Littleton W.H., Flannery D.B., Hurley L.S. Association of low blood manganese concentrations with epilepsy. Neurology 1986, 36:1584-1587.
15. Carr C.W., Moreno-De-Luca D., Parker C., Zimmerman H.H., Ledbetter N., Martin C.L., Dobyns W.B., Abdul-Rahman O.A. Chiari I malformation, delayed gross motor skills, severe speech delay, and epileptiform discharges in a child with FOXP1 haploinsufficiency. Eur. J. Hum. Genet. 2010, in press. Published online June 23, 2010.
16. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 2010, 11:415-425.
17. Clark A., O'Hare A., Watson J., Cohen W., Cowie H., Elton R., Nasir J., Seckl J. Severe receptive language disorder in childhood-familial aspects and long-term outcomes: Results from a Scottish study. Arch. Dis. Child. 2007, 92:614-619.
18. Conti-Ramsden G., Botting N. Characteristics of children attending language units in England: A national study of 7-year-olds. Int. J. Lang. Commun. Disord. 1999, 34:359-366.
19. Conti-Ramsden G., Botting N., Simkin Z., Knox E. Follow-up of children attending infant language units: Outcomes at 11 years of age. Int. J. Lang. Commun. Disord. 2001, 36:207-219.
20. Conti-Ramsden G., Falcaro M., Simkin Z., Pickles A. Familial loading in specific language impairment: Patterns of differences across proband characteristics, gender and relative type. Genes Brain Behav. 2007, 6:216-228.
21. Cook E.H., Courchesne R.Y., Cox N.J., Lord C., Gonen D., Guter S.J., Lincoln A., Nix K., Haas R., Leventhal B.L., Courchesne E. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 1998, 62:1077-1083.
22. Corvin A.P. Neuronal cell adhesion genes: Key players in risk for schizophrenia, bipolar disorder and other neurodevelopmental brain disorders?. Cell. Adh. Migr. 2010, 4:509-512.
23. Dasen J.S., De Camilli A., Wang B., Tucker P.W., Jessell T.M. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 2008, 134:304-316.
24. Dash P.K., Moore A.N., Kobori N., Runyan J.D. Molecular activity underlying working memory. Learn. Mem. 2007, 14:554-563.
25. Davila S., Froeling F.E., Tan A., Bonnard C., Boland G.J., Snippe H., Hibberd M.L., Seielstad M. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010, 11:232-238.
26. Elia J., Gai X., Xie H.M., Perin J.C., Geiger E., Glessner J.T., D'arcy M., deBerardinis R., Frackelton E., Kim C., et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 2010, 15:637-646.
27. Elston R.C., Anne Spence M. Advances in statistical human genetics over the last 25 years. Stat. Med. 2006, 25:3049-3080.
28. Falcaro M., Pickles A., Newbury D.F., Addis L., Banfield E., Fisher S.E., Monaco A.P., Simkin Z., Conti-Ramsden G. Genetic and phenotypic effects of phonological short-term memory and grammatical morphology in specific language impairment. Genes Brain Behav. 2008, 7:393-402. SLI Consortium.
29. Felsenfeld S., Kirk K.M., Zhu G., Statham D.J., Neale M.C., Martin N.G. A study of the genetic and environmental etiology of stuttering in a selected twin sample. Behav. Genet. 2000, 30:359-366.
30. Ferland R.J., Cherry T.J., Preware P.O., Morrisey E.E., Walsh C.A. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J. Comp. Neurol. 2003, 460:266-279.
31. Feuk L., Kalervo A., Lipsanen-Nyman M., Skaug J., Nakabayashi K., Finucane B., Hartung D., Innes M., Kerem B., Nowaczyk M.J., et al. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am. J. Hum. Genet. 2006, 79:965-972.
32. Fisher S.E. Tangled webs: Tracing the connections between genes and cognition. Cognition 2006, 101:270-297.
33. Fisher S.E., Scharff C. FOXP2 as a molecular window into speech and language. Trends Genet. 2009, 25:166-177.
34. Fisher S.E., Vargha-Khadem F., Watkins K.E., Monaco A.P., Pembrey M.E. Localisation of a gene implicated in a severe speech and language disorder. Nat. Genet. 1998, 18:168-170.
35. Fox S.B., Brown P., Han C., Ashe S., Leek R.D., Harris A.L., Banham A.H. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas. Clin. Cancer Res. 2004, 10:3521-3527.
36. Friedman J.I., Vrijenhoek T., Markx S., Janssen I.M., van der Vliet W.A., Faas B.H., Knoers N.V., Cahn W., Kahn R.S., Edelmann L., et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 2008, 13:261-266.
37. Gabel L.A., Gibson C.J., Gruen J.R., LoTurco J.J. Progress towards a cellular neurobiology of reading disability. Neurobiol. Dis. 2010, 38:173-180.
38. Galaburda A.M., Sherman G.F., Rosen G.D., Aboitiz F., Geschwind N. Developmental dyslexia: Four consecutive patients with cortical anomalies. Ann. Neurol. 1985, 18:222-233.
39. Gauthier J., Joober R., Mottron L., Laurent S., Fuchs M., De Kimpe V., Rouleau G.A. Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. Am. J. Med. Genet. A. 2003, 118A:172-175.
40. Grimbert P., Valanciute A., Audard V., Pawlak A., Le gouvelo S., Lang P., Niaudet P., Bensman A., Guellaën G., Sahali D. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J. Exp. Med. 2003, 198:797-807.
41. Grimbert P., Valanciute A., Audard V., Lang P., Guellaën G., Sahali D. The Filamin-A is a partner of Tc-mip, a new adapter protein involved in c-maf-dependent Th2 signaling pathway. Mol. Immunol. 2004, 40:1257-1261.
42. Hannenhalli S., Kaestner K.H. The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 2009, 10:233-240.
43. Harel S., Greenstein Y., Kramer U., Yifat R., Samuel E., Nevo Y., Leitner Y., Kutai M., Fattal A., Shinnar S. Clinical characteristics of children referred to a child development center for evaluation of speech, language, and communication disorders. Pediatr. Neurol. 1996, 15:305-311.
44. Hayiou-Thomas M.E. Genetic and environmental influences on early speech, language and literacy development. J. Commun. Disord. 2008, 41:397-408.
45. Heng J.I., Chariot A., Nguyen L. Molecular layers underlying cytoskeletal remodelling during cortical development. Trends Neurosci. 2010, 33:38-47.
46. Horn D., Kapeller J., Rivera-Brugués N., Moog U., Lorenz-Depiereux B., Eck S., Hempel M., Wagenstaller J., Gawthrope A., Monaco A.P., et al. Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits. Hum. Mutat. 2010, in press. Published online September 16, 2010.
47. Jackman C., Horn N.D., Molleston J.P., Sokol D.K. Gene associated with seizures, autism, and hepatomegaly in an Amish girl. Pediatr. Neurol. 2009, 40:310-313.
48. Jais J.P., Haioun C., Molina T.J., Rickman D.S., de Reynies A., Berger F., Gisselbrecht C., Brière J., Reyes F., Gaulard P., et al. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia 2008, 22:1917-1924. Groupe d'Etude des Lymphomes de l'Adulte.
49. Jin Y., Birlea S.A., Fain P.R., Mailloux C.M., Riccardi S.L., Gowan K., Holland P.J., Bennett D.C., Wallace M.R., McCormack W.T., et al. Common variants in FOXP1 are associated with generalized vitiligo. Nat. Genet. 2010, 42:576-578.
50. Kamal M., Valanciute A., Dahan K., Ory V., Pawlak A., Lang P., Guellaen G., Sahali D. C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity. Mol. Immunol. 2009, 46:991-998.
51. Kamal M., Pawlak A., BenMohamed F., Valanciuté A., Dahan K., Candelier M., Lang P., Guellaën G., Sahali D. C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase. FEBS Lett. 2010, 584:500-506.
52. Kang C., Riazuddin S., Mundorff J., Krasnewich D., Friedman P., Mullikin J.C., Drayna D. Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering. N. Engl. J. Med. 2010, 362:677-685.
53. Konstantoulas C.J., Parmar M., Li M. FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3. J. Neurochem. 2010, 113:836-847.
54. Lai C.S., Fisher S.E., Hurst J.A., Levy E.R., Hodgson S., Fox M., Jeremiah S., Povey S., Jamison D.C., Green E.D., et al. The SPCH1 region on human 7q31: Genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am. J. Hum. Genet. 2000, 67:357-368.
55. Lai C.S., Fisher S.E., Hurst J.A., Vargha-Khadem F., Monaco A.P. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001, 413:519-523.
56. Laroche F., Ramoz N., Leroy S., Fortin C., Rousselot-Paillet B., Philippe A., Colleaux L., Bresson J.L., Mogenet A., Golse B., et al. Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr. Genet. 2008, 18:295-301.
57. Law J., Boyle J., Harris F., Harkness A., Nye C. Prevalence and natural history of primary speech and language delay: Findings from a systematic review of the literature. Int. J. Lang. Commun. Disord. 2000, 35:165-188.
58. Lennon P.A., Cooper M.L., Peiffer D.A., Gunderson K.L., Patel A., Peters S., Cheung S.W., Bacino C.A. Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: Clinical report and review. Am. J. Med. Genet. A. 2007, 143:791-798.
59. Lesch K.P., Timmesfeld N., Renner T.J., Halperin R., Röser C., Nguyen T.T., Craig D.W., Romanos J., Heine M., Meyer J., et al. Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural Transm. 2008, 115:1573-1585.
60. Lewis B.A., Freebairn L.A., Hansen A.J., Miscimarra L., Iyengar S.K., Taylor H.G. Speech and language skills of parents of children with speech sound disorders. Am. J. Speech Lang. Pathol. 2007, 16:108-118.
61. Li S., Weidenfeld J., Morrisey E.E. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol. Cell. Biol. 2004, 24:809-822.
62. Li H., Yamagata T., Mori M., Momoi M.Y. Absence of causative mutations and presence of autism-related allele in FOXP2 in Japanese autistic patients. Brain Dev. 2005, 27:207-210.
63. Li B., Samanta A., Song X., Iacono K.T., Brennan P., Chatila T.A., Roncador G., Banham A.H., Riley J.L., Wang Q., et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 2007, 19:825-835.
64. Lu M.M., Li S., Yang H., Morrisey E.E. Foxp4: A novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues. Gene Expr. Patterns 2002, 2:223-228.
65. Lunetta K.L., Faraone S.V., Biederman J., Laird N.M. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am. J. Hum. Genet. 2000, 66:605-614.
66. MacDermot K.D., Bonora E., Sykes N., Coupe A.M., Lai C.S., Vernes S.C., Vargha-Khadem F., McKenzie F., Smith R.L., Monaco A.P., Fisher S.E. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am. J. Hum. Genet. 2005, 76:1074-1080.
67. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
68. Marui T., Koishi S., Funatogawa I., Yamamoto K., Matsumoto H., Hashimoto O., Nanba E., Kato C., Ishijima M., Watanabe K., et al. No association of FOXP2 and PTPRZ1 on 7q31 with autism from the Japanese population. Neurosci. Res. 2005, 53:91-94.
69. Maunakea A.K., Chepelev I., Zhao K., Bruneau B. Epigenome mapping in normal and disease States. Circ. Res. 2010, 107:327-339.
70. McCarthy M.I., Hirschhorn J.N. Genome-wide association studies: Potential next steps on a genetic journey. Hum. Mol. Genet. 2008, 17(R2):R156-R165.
71. Meaburn E., Dale P.S., Craig I.W., Plomin R. Language-impaired children: No sign of the FOXP2 mutation. Neuroreport 2002, 13:1075-1077.
72. Mefford H.C., Muhle H., Ostertag P., von Spiczak S., Buysse K., Baker C., Franke A., Malafosse A., Genton P., Thomas P., et al. Genome-wide copy number variation in epilepsy: Novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet. 2010, 6:e1000962.
73. Miscimarra L., Stein C., Millard C., Kluge A., Cartier K., Freebairn L., Hansen A., Shriberg L., Taylor H.G., Lewis B., Iyengar S.K. Further evidence of pleiotropy influencing speech and language: Analysis of the DYX8 region. Hum. Hered. 2007, 63:47-58.
74. Monaco A.P. Multivariate linkage analysis of specific language impairment (SLI). Ann. Hum. Genet. 2007, 71:660-673.
75. Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O. Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 2000, 7:347-355.
76. Newbury D.F., Bonora E., Lamb J.A., Fisher S.E., Lai C.S., Baird G., Jannoun L., Slonims V., Stott C.M., Merricks M.J., et al. FOXP2 is not a major susceptibility gene for autism or specific language impairment. Am. J. Hum. Genet. 2002, 70:1318-1327. International Molecular Genetic Study of Autism Consortium.
77. Newbury D.F., Winchester L., Addis L., Paracchini S., Buckingham L.L., Clark A., Cohen W., Cowie H., Dworzynski K., Everitt A., et al. CMIP and ATP2C2 modulate phonological short-term memory in language impairment. Am. J. Hum. Genet. 2009, 85:264-272.
78. O'Brien E.K., Zhang X., Nishimura C., Tomblin J.B., Murray J.C. Association of specific language impairment (SLI) to the region of 7q31. Am. J. Hum. Genet. 2003, 72:1536-1543.
79. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry 2010, The International Schizophrenia Consortium, in press. Published online February 16, 2010.
80. Paik K.H., Song S.M., Ki C.S., Yu H.W., Kim J.S., Min K.H., Chang S.H., Yoo E.J., Lee I.J., Kwan E.K., et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum. Mutat. 2005, 26:308-314.
81. Palmesino E., Rousso D.L., Kao T.J., Klar A., Laufer E., Uemura O., Okamoto H., Novitch B.G., Kania A. Foxp1 and lhx1 coordinate motor neuron migration with axon trajectory choice by gating Reelin signalling. PLoS Biol. 2010, 8:e1000446.
82. Panaitof S.C., Abrahams B.S., Dong H., Geschwind D.H., White S.A. Language-related Cntnap2 gene is differentially expressed in sexually dimorphic song nuclei essential for vocal learning in songbirds. J. Comp. Neurol. 2010, 518:1995-2018.
83. Pariani M.J., Spencer A., Graham J.M., Rimoin D.L. A 785kb deletion of 3p14.1p13, including the FOXP1 gene, associated with speech delay, contractures, hypertonia and blepharophimosis. Eur. J. Med. Genet. 2009, 52:123-127.
84. Perl D.P., Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 2007, 66:675-682.
85. Peterson R.L., Pennington B.F., Shriberg L.D., Boada R. What influences literacy outcome in children with speech sound disorder?. J. Speech Lang. Hear. Res. 2009, 52:1175-1188.
86. Poliak S., Salomon D., Elhanany H., Sabanay H., Kiernan B., Pevny L., Stewart C.L., Xu X., Chiu S.Y., Shrager P., et al. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. Cell Biol. 2003, 162:1149-1160.
87. Poot M., Beyer V., Schwaab I., Damatova N., Van't Slot R., Prothero J., Holder S.E., Haaf T. Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics 2010, 11:81-89.
88. Prasse J.E., Kikano G.E. Stuttering: An overview. Am. Fam. Physician 2008, 77:1271-1276.
89. Raas-Rothschild A., Cormier-Daire V., Bao M., Genin E., Salomon R., Brewer K., Zeigler M., Mandel H., Toth S., Roe B., et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J. Clin. Invest. 2000, 105:673-681.
90. Raitano N.A., Pennington B.F., Tunick R.A., Boada R., Shriberg L.D. Pre-literacy skills of subgroups of children with speech sound disorders. J. Child Psychol. Psychiatry 2004, 45:821-835.
91. Raza M.H., Riazuddin S., Drayna D. Identification of an autosomal recessive stuttering locus on chromosome 3q13.2-3q13.33. Hum. Genet. 2010, 128:461-463.
92. Riaz N., Steinberg S., Ahmad J., Pluzhnikov A., Riazuddin S., Cox N.J., Drayna D. Genomewide significant linkage to stuttering on chromosome 12. Am. J. Hum. Genet. 2005, 76:647-651.
93. Rice M.L., Smith S.D., Gayán J. Convergent genetic linkage and associations to language, speech and reading measures in families of probands with Specific Language Impairment. J Neurodev Disord 2009, 1:264-282.
94. Rossi E., Verri A.P., Patricelli M.G., Destefani V., Ricca I., Vetro A., Ciccone R., Giorda R., Toniolo D., Maraschio P., Zuffardi O. A 12Mb deletion at 7q33-q35 associated with autism spectrum disorders and primary amenorrhea. Eur. J. Med. Genet. 2008, 51:631-638.
95. Rousso D.L., Gaber Z.B., Wellik D., Morrisey E.E., Novitch B.G. Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron 2008, 59:226-240.
96. Scerri T.S., Schulte-Körne G. Genetics of developmental dyslexia. Eur. Child Adolesc. Psychiatry 2010, 19:179-197.
97. Schroeder D.I., Myers R.M. Multiple transcription start sites for FOXP2 with varying cellular specificities. Gene 2008, 413:42-48.
98. Shriberg L.D., Tomblin J.B., McSweeny J.L. Prevalence of speech delay in 6-year-old children and comorbidity with language impairment. J. Speech Lang. Hear. Res. 1999, 42:1461-1481.
99. Shriberg L.D., Ballard K.J., Tomblin J.B., Duffy J.R., Odell K.H., Williams C.A. Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2. J. Speech Lang. Hear. Res. 2006, 49:500-525.
100. Shu W., Yang H., Zhang L., Lu M.M., Morrisey E.E. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J. Biol. Chem. 2001, 276:27488-27497.
101. Shu W., Lu M.M., Zhang Y., Tucker P.W., Zhou D., Morrisey E.E. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007, 134:1991-2000.
102. Shugart Y.Y., Mundorff J., Kilshaw J., Doheny K., Doan B., Wanyee J., Green E.D., Drayna D. Results of a genome-wide linkage scan for stuttering. Am. J. Med. Genet. A. 2004, 124A:133-135.
103. Sices L., Taylor H.G., Freebairn L., Hansen A., Lewis B. Relationship between speech-sound disorders and early literacy skills in preschool-age children: Impact of comorbid language impairment. J. Dev. Behav. Pediatr. 2007, 28:438-447.
104. A genomewide scan identifies two novel loci involved in specific language impairment. Am. J. Hum. Genet. 2002, 70:384-398. SLI Consortium.
105. Highly significant linkage to the SLI1 locus in an expanded sample of individuals affected by specific language impairment. Am. J. Hum. Genet. 2004, 74:1225-1238. SLI Consortium (SLIC).
106. Smith S.D., Pennington B.F., Boada R., Shriberg L.D. Linkage of speech sound disorder to reading disability loci. J. Child Psychol. Psychiatry 2005, 46:1057-1066.
107. Spiteri E., Konopka G., Coppola G., Bomar J., Oldham M., Ou J., Vernes S.C., Fisher S.E., Ren B., Geschwind D.H. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am. J. Hum. Genet. 2007, 81:1144-1157.
108. Stein C.M., Schick J.H., Gerry Taylor H., Shriberg L.D., Millard C., Kundtz-Kluge A., Russo K., Minich N., Hansen A., Freebairn L.A., et al. Pleiotropic effects of a chromosome 3 locus on speech-sound disorder and reading. Am. J. Hum. Genet. 2004, 74:283-297.
109. Stein C.M., Millard C., Kluge A., Miscimarra L.E., Cartier K.C., Freebairn L.A., Hansen A.J., Shriberg L.D., Taylor H.G., Lewis B.A., Iyengar S.K. Speech sound disorder influenced by a locus in 15q14 region. Behav. Genet. 2006, 36:858-868.
110. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 2006, 354:1370-1377.
111. Suresh R., Ambrose N., Roe C., Pluzhnikov A., Wittke-Thompson J.K., Ng M.C., Wu X., Cook E.H., Lundstrom C., Garsten M., et al. New complexities in the genetics of stuttering: Significant sex-specific linkage signals. Am. J. Hum. Genet. 2006, 78:554-563.
112. Tan G.C., Doke T.F., Ashburner J., Wood N.W., Frackowiak R.S. Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2. Neuroimage 2010, 53:1030-1042.
113. Terracciano A., Sanna S., Uda M., Deiana B., Usala G., Busonero F., Maschio A., Scally M., Patriciu N., Chen W.M., et al. Genome-wide association scan for five major dimensions of personality. Mol. Psychiatry 2010, 15:647-656.
114. Tomblin J.B., O'Brien M., Shriberg L.D., Williams C., Murray J., Patil S., Bjork J., Anderson S., Ballard K. Language features in a mother and daughter of a chromosome 7;13 translocation involving FOXP2. J. Speech Lang. Hear. Res. 2009, 52:1157-1174.
115. Vargha-Khadem F., Watkins K., Alcock K., Fletcher P., Passingham R. Praxic and nonverbal cognitive deficits in a large family with a genetically transmitted speech and language disorder. Proc. Natl. Acad. Sci. USA 1995, 92:930-933.
116. Verkerk A.J., Mathews C.A., Joosse M., Eussen B.H., Heutink P., Oostra B.A. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82:1-9. Tourette Syndrome Association International Consortium for Genetics.
117. Vernes S.C., Spiteri E., Nicod J., Groszer M., Taylor J.M., Davies K.E., Geschwind D.H., Fisher S.E. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am. J. Hum. Genet. 2007, 81:1232-1250.
118. Vernes S.C., Newbury D.F., Abrahams B.S., Winchester L., Nicod J., Groszer M., Alarcón M., Oliver P.L., Davies K.E., Geschwind D.H., et al. A functional genetic link between distinct developmental language disorders. N. Engl. J. Med. 2008, 359:2337-2345.
119. Vernes S.C., MacDermot K.D., Monaco A.P., Fisher S.E. Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia. Eur. J. Hum. Genet. 2009, 17:1354-1358.
120. Wadman R., Durkin K., Conti-Ramsden G. Self-esteem, shyness, and sociability in adolescents with specific language impairment (SLI). J. Speech Lang. Hear. Res. 2008, 51:938-952.
121. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., Folstein S.E., Sheffield V.C. Evaluation of FOXP2 as an autism susceptibility gene. Am. J. Med. Genet. 2002, 114:566-569.
122. Watkins K.E., Dronkers N.F., Vargha-Khadem F. Behavioural analysis of an inherited speech and language disorder: Comparison with acquired aphasia. Brain 2002, 125:452-464.
123. Wittke-Thompson J.K., Ambrose N., Yairi E., Roe C., Cook E.H., Ober C., Cox N.J. Genetic studies of stuttering in a founder population. J. Fluency Disord. 2007, 32:33-50.
124. Zeesman S., Nowaczyk M.J., Teshima I., Roberts W., Cardy J.O., Brian J., Senman L., Feuk L., Osborne L.R., Scherer S.W. Speech and language impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2. Am. J. Med. Genet. A. 2006, 140:509-514.
125. Zweier C., de Jong E.K., Zweier M., Orrico A., Ousager L.B., Collins A.L., Bijlsma E.K., Oortveld M.A., Ekici A.B., Reis A., et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am. J. Hum. Genet. 2009, 85:655-666.